Characteristics of Anticancer Drugs Approved Under the Accelerated Approval Program in the US: Success or Failure in Converting to Regular Approval-论文-万方医学网

首页> > Characteristics of Anticancer Drugs Approved Under the Accelerated Approval Program in the US: Success or Failure in Converting to Regular Approval

Characteristics of Anticancer Drugs Approved Under the Accelerated Approval Program in the US: Success or Failure in Converting to Regular Approval

导出原文传递

翻译打印收藏纠错

第一作者： Oda, Yoshihiro

作者： Oda, Yoshihiro ^[1] ; Narukawa, Mamoru

作者单位： Seattle Quilcene BiostatJohns Hopkins Bloomberg Sch Publ Hlth Johns Hopkins University Johns ^[1]

关键词 Accelerated approval Anticancer drug Confirmatory trial Response rate Withdrawn OPEN-LABEL CHEMOTHERAPY MULTICENTER

发布时间 2024-04-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Characteristics of Anticancer Drugs Approved Under the Accelerated Approval Program in the US: Success or Failure in Converting to Regular Approval

相似文献

同项目论文

相关期刊

检索历史 清除

Characteristics of Anticancer Drugs Approved Under the Accelerated Approval Program in the US: Success or Failure in Converting to Regular Approval

相似文献

同项目论文

相关期刊

检索历史清除